Korean J Physiol Pharmacol.  2008 Oct;12(5):217-223. 10.4196/kjpp.2008.12.5.217.

Role of Glucocorticoids in Fasting-induced Changes in Hypothalamic and Pituitary Components of the Growth Hormone (GH)-axis

• Kim E
• Seo S
• Chung H
• Park S

• KMID: 1486102
• DOI: http://doi.org/10.4196/kjpp.2008.12.5.217

Abstract

To directly test if elevated glucocorticoids are required for fasting-induced regulation of growth hormone (GH)-releasing hormone (GHRH), GHRH receptors (GHRH-R) and ghrelin receptors (GHS-R) expression, male rats were bilaterally adrenalectomized or sham operated. After 7 days, animals were fed ad libitum or fasted for 48 h. Bilateral adrenalectomy increased hypothalamic GHRH to 146% and decreased neuropeptide Y (NPY) mRNA to 54% of SHAM controls. Pituitary GHRH-R and GHS-R mRNA levels were decreased by adrenalectomy to 30% and 80% of sham-operated controls. In sham- operated rats, fasting suppressed hypothalamic GHRH (49%) and stimulated NPY (166%) mRNA levels, while fasting increased pituitary GHRH-R (391%) and GHS-R (218%) mRNA levels. However, in adrenalectomized rats, fasting failed to alter pituitary GHRH-R mRNA levels, while the fasting-induced suppression of GHRH and elevation of NPY and GHS-R mRNA levels remained intact. In fasted adrenalectomized rats, corticosterone replacement increased GHRH-R mRNA levels and intensified the fasting-induced decrease in GHRH, but did not alter NPY or GHS-R response. These data suggest that elevated glucocorticoids mediate the effects of fasting on hypothalamic GHRH and pituitary GHRH-R expression, while glucocorticoids are likely not the major determinant in fasting-induced increases in hypothalamic NPY and pituitary GHS-R expression.

Keyword

Glucocorticoids; Fasting; Growth hormone-releasing hormone (GHRH); GHRH receptor; Growth hormone secretagogue (GHS) receptor; Adrenalectomy

MeSH Terms

Adrenalectomy
Animals
Corticosterone
Fasting
Glucocorticoids
Growth Hormone
Humans
Male
Neuropeptide Y
Rats
Receptors, Ghrelin
Receptors, Neuropeptide
Receptors, Pituitary Hormone-Regulating Hormone
RNA, Messenger
Salicylamides
Corticosterone
Glucocorticoids
Growth Hormone
Neuropeptide Y
RNA, Messenger
Receptors, Ghrelin
Receptors, Neuropeptide
Receptors, Pituitary Hormone-Regulating Hormone
Salicylamides

Figure

• 

  Fig. 1. Comparison of the body weight (A) and plasma corticosterone levels (B) of sham-operated (Sham) and adren-alectomized (ADX) animals and effect of adrenalectomy on hypothalamic (C) and pituitary (D) gene expression. Body weight was displayed % of change between immediately before operation and immediately before sacrifice. Serum corticosterone was measured by ELISA. Hypothalamic and pituitary gene expressions were measured by real-time RT-PCR. Data are mean±S.E.M., n=5 animals/group. ∗p<0.05.

• 

  Fig. 2. Effect of fasting on body weight (A, B), serum glucose (C), circulating growth hormone (GH) (D), insulinlike growth factor (IGF)-1 (E) and corticosterone (F) in sham-operated (Sham) and adrenalectomized (ADX) rats. Serum glucose levels were measured by GlucoDr Blood Glucose Meter. Serum GH concentrations were measured by GH RIA. Serum IGF-1 and corticosterone levels were measured by ELISA. Values are expressed as mean±SEM., n=5 animals/group. ∗, indicates values differ from respective fed controls; ∗, p< 0.05.

• 

  Fig. 3. Effect of fasting on hypothalamic neuropeptide Y (NPY), growth hormone-releasing hormone (GHRH), and somatostatin (SRIH) mRNA levels in sham-operated (A) or adrenalectomized (B) animals. Animals were fasted for 24 h, 48 h, 72 h or supplied food ad libitum (fed). Both groups were allowed free access to water or 0.9% NaCl solution (adrenalectomized group). Hyperthalamic mRNA levels were measured by real-time RT-PCR and adjusted with β-actin. The graph is expressed as a percentage of fed controls. Data are mean±S.E.M., n=5 animals/group. ∗, indicates values differ from respective fed controls; ∗, p< 0.05.

• 

  Fig. 4. Effect of fasting on pituitary growth hormone (GH)-releasing hormone receptor (GHRH-R) (A), GH secretagogue receptor (GHS-R) (B), and GH (C) mRNA levels in adrenalectomized or shamoperated animals. Animals were fasted for 24 h, 48 h, 72 h or supplied food ad libitum (fed). Both groups were allowed free access to water or 0.9% NaCl solution (adrenalectomized group). GHRH-R, GHS-R, and GH mRNA levels were measured by real-time RT-PCR and adjusted with β-actin. The graph is expressed as a percentage of fed controls. Data are mean±S.E.M., n=5 animals/group. ∗, indicates values differ from respective fed controls; ∗, p<0.05.

• 

  Fig. 5. Effect of corticosterone (C) on pituitary (A) and hypothalamic (B) gene expression in adrenalectomized animals. Animals were fasted for 48 h or supplied food ad libitum (fed). Subsets of fed or 48 h fasted rats were provided with 40μg/ml of corticosterone containing water from immediately after operation to immediately before sacrifice. Hypothalamic and pituitary mRNAs were measured by real-time RT-PCR. Data are mean±S.E.M., n=5 animals/group. ∗, indicates values differ from respective fed controls; ∗, p<0.05, #, p< 0.05.

Reference

Alvarez CV., Mallo F., Burguera B., Cacicedo L., Dieguez C., Casanueva FF. Evidence for a direct pituitary inhibition by free fatty acids of in vivo growth hormone responses to growth hormone- releasing hormone in the rat. Neuroendocrinology. 53:185–189. 1991.

Ariyasu H., Takaya K., Tagami T., Ogawa Y., Hosoda K., Akamizu T., Suda M., Koh T., Natsui K., Toyooka S., Shirakami G., Usui T., Shimatsu A., Doi K., Hosoda H., Kojima M., Kangawa K., Nakao K. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab. 86:4753–4758. 2001.

Bornfeldt KE., Arnqvist HJ., Enberg B., Matthews LS., Norstedt G. Regulation of insulin-like growth factor-1 and growth hormone receptor gene expression by diabetes and nutritional state in rat tissues. J Endocrinol. 122:651–656. 1989.

Bruno JF., Olchovsky D., White JD., Leidy JW., Song J., Berelowitz M. Influence of food deprivation in the rat on hypothalamic expression of growth hormone-releasing factor and somatostatin. Endocrinology. 127:2111–2116. 1990.

Bruno JF., Xu Y., Song J., Berelowitz M. Pituitary and hypothalamic somatostatin receptor subtype messenger ribonucleic acid expression in the food-deprived and diabetic rat. Endocrinology. 135:1787–1792. 1994.

Carro E., Senaris RM., Seoane LM., Frohman LA., Arimura A., Casaneuva FF., Dieguez C. Role of GHRH and somatostatin on leptin-induced GH secretion. Neuroendocrinology. 69:3–10. 1999.

Casaneuva FF., Villanueva L., Dieguez C., Diaz Y., Cabranes JA., Szoke B., Scanlon MF., Schally AV., Fernandez-Cruz A. Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary. J Clin Endocrinol Metab. 65:634–642. 1987.

Fairhall KM., Gabrielsson BG., Robinson ICAF. Effect of food withdrawal and insulin on growth hormone secretion in the guinea pig. Endocrinology. 127:716–723. 1990.

Fife SK., Brogan RS., Giustina A., Wehrenberg WB. Immunocyto-chemical and molecular analysis of the effects of glucocorticoid treatment on the hypothalamic-somatotropic axis in the rat. Neuroendocrinology. 64:131–138. 1996.

Ghigo MC., Torsello A., Grilli R., Luoni M., Locatelli V., Muller EE. Effects of GH and IGF-I administration on GHRH and somatostatin mRNA levels: I. A study on ad libitum fed and starved adult male rats. J Endocrinol Invest. 20:144–150. 1997.

Gianotti L., Pincelli AI., Scacchi M., Rolla M., Bellitti D., Arvat E., Lanfranco F., Torsello A., Ghigo E., Cavagnini R., Muller EE. Effects of recombinant human insulin-like growh factor I administration on spontaneous and growth hormone (GH)-releasing hormone-stimulated GH secretion in anorexia nervosa. J Clin Endocrinol Metab. 85:2805–2809. 2000.

Gianotti L., Rolla M., Arvat E., Belliti D., Valleto MR., Ferdeghini M., Ghigo E., Mueller EE. Effect of somatostatin infusion on the somatotrope responsiveness to growth hormone-releasing hormone in patients with anorexia nervosa. Biol Psychiat. 45:334–339. 1999.

Hanson ES., Levin N., Dallman MF. Elevated corticosterone is not required for the rapid induction of neuropeptide Y expression by an overnight fast. Endocrinology. 138:1041–1047. 1997.

Henricks DM., Jenkins TC., Ward JR., Krishnan CS., Grimes L. Endocrine responses and body composition changes during feed restriction and realimentation in young bulls. J Anim Sci. 72:2289–2297. 1994.

Ho KY., Veldhuis JD., Johnson ML., Furlanetto R., Evans WS., Alberti KGMM., Thorner MO. Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. J Clin Invest. 81:968–975. 1988.

Ho PJ., Friberg RD., Barkan AL. Regulation of pulsatile growth hormone secretion by fasting in normal subjects and patients with acromegaly. J Clin Endocrinol Metab. 75:812–819. 1992.

Janowski BA., Ling NC., Giustina A., Wehrenberg WB. Hypothalamic regulation of growth hormone secretion during food deprivation in the rat. Life Sci. 52:981–987. 1993.

Kamegai J., Tamura H., Shimizu T., Ishii S., Sugihara H., Wakabayashi I. Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats. Diabetes. 50:2438–2443. 2001.

Kamegai J., Unterman TG., Frohman LA., Kineman RD. Hypothalamic/pituitary-axis of the spontaneous dwarf rat: autofeedback regulation of growth hormone (GH) includes suppression of GH releasing-hormone receptor messenger ribonucleic acid. Endocrinology. 139:3554–3560. 1998a.

Kamegai J., Wakabayashi I., Miyamoto K., Unterman TG., Kineman RD., Frohman LA. Growth hormone (GH)-dependent regulation of pituitary GH secretagogue receptor (GHS-R) mRNA levels in the spontaneous dwarf rat. Neuroendocrinology. 68:312–318. 1998b.

Kim E., Sohn S., Lee M., Jung J., Kineman RD., Park S. Differential responses of the growth hormone axis in two rat models of streptozotocin-induced insulinopenic diabetes. J Endocrinol. 188:263–270. 2006.

Kim MS., Yoon CY., Park KH., Shin CS., Park KS., Kim SY., Cho BY., Lee HK. Changes in ghrelin and ghrelin receptor expression according to feeding status. Neuroreport. 14:1317–1320. 2003.

Korbonits M., Little JA., Forsling L., Tringali G., Costa A., Navarra P., Trainer PJ., Grossman AB. The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants. J Neuroendocrinol. 11:521–528. 1999.

Lam KS., Lee MF., Tam SP., Srivastava G. Gene expression of the receptor for growth hormone-releasing hormone is physiologically regulated by glucocorticoids and estrogen. Neuroendocrinology. 63:475–480. 1996.

Lam KS., Srivastava G. Gene expression of hypothalamic somatostatin and growth hormone-releasing hormone in dexamethasone-treated rats. Neuroendocrinology. 66:2–8. 1997.

Maccario M., Procopio M., Loche S., Cappa M., Martina V., Camanni F., Ghigo E. Interaction of free fatty acids and arginine on growth hormone secretion in man. Metabolism. 43:223–226. 1994.

Miller TL., Mayo KE. Glucocorticoids regulate pituitary growth hormone-releasing hormone receptor messenger ribonucleic acid expression. Endocrinology. 138:2458–2465. 1997.

Minami S., Kamegai J., Sugihara H., Suzuki N., Wakabayashi I. Growth hormone inhibits its own secretion by acting on the hypothalamus through its receptors on neuropeptide Y neurons in the arcuate nucleus and somatostatin neurons in the periventricular nucleus. Endocr J. 48(Suppl):19–26. 1998.

Obici S., Feng Z., Morgan K., Stein D., Karkanias G., Rossetti L. Central administration of oleic acid inhibits glucose production and food intake. Diabetes. 51:271–275. 2002.

Ohyama T., Sato M., Ohye H., Murao K., Niimi M., Takahara J. Effects of adrenalectomy and glucocorticoid receptor antagonist, RU38486, on pituitary growth hromone-releasing hormone receptor gene expression in rats. Peptides. 19:1063–1067. 1998.

Park S., Sohn S., Kineman RD. Fasting-induced changes in the hypothalamic-pituitary-GH axis in the absence of GH expression: lessons from the spontaneous dwarf rat. J Endocrinol. 180:369–378. 2004.

Riedel M., Hoeft B., Blum WF., von zur Muhlen A., Brabant G. Pulsatile growth hormone secretion in normal-weight and obese men: differential metabolic regulation during energy restriction. Metabolism. 44:605–610. 1995.

Senaris RM., Lago F., Coya R., Pineda J., Dieguez C. Regulation of hypothalamic somatostatin, growth hormone- releasing hormone, and growth hormone receptor messenger ribonucleic acid by glucocorticoids. Endocrinology. 137:5236–5241. 1996.

Shintani M., Ogawa Y., Ebihara K., Aizawa-Abe M., Miyanaga F., Takaya K., Hayashi T., Inoue G., Hosoda K., Kojima M., Kangawa K., Nakao K. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes. 50:227–232. 2001.

Stoving RK., Veldhuis JD., Flyvbjerg A., Vinten J., Hangaard J., Koldkjaer OG., Kristiansen J., Hagen C. Jointly amplified basal and pulasatile growth hormone (GH) secretion and increased process irregularity in women with anorexia nervosa: indirect evidence for disruption of feedback regulation within the GH-Insulin-like growth factor 1 axis. J Clin Endocrinol Metab. 84:2056–2063. 1999.

Sugihara H., Emoto N., Shibasaki T., Minami S., Wakabayashi I. Increased pituitary growth hormone-releasing factor (GRF) receptor messenger ribonucleic acid expression in food-deprived rats. Brain Res. 742:355–358. 1996.

Tamura H., Kamegai J., Sugihara H., Kineman RD., Frohman LA., Wakabayashi I. Glucocorticoids regulate pituitary growth hormone secretagogue receptor gene expression. J Neuroendocrinol. 12:481–485. 2000.

Tannenbaum GS., Rorstad O., Brazeau P. Effects of prolonged food deprivation on the ultradian growth hormone rhythm and immunoreactive somatostatin tissue levels in the rat. Endocrinology. 104:1733–1738. 1979.

Thomas GB., Bennett PA., Carmignac DF., Robinson ICAF. Glucocorticoid regulation of growth hormone (GH) secretagogue-induced growth responses and GH secretagogue receptor expression in the rat. Growth Horm IGF Res. 10:45–52. 2000.

Thomas GB., Mercer JE., Karalis T., Rao A., Cummins JT., Clarke IJ. Effect of restricted feeding on the concentrations of growth hormone (GH), gonadotropins, and prolactin (PRL) in plasma, and on the amounts of messenger ribonucleic acid for GH, gonadotropin subunits, and PRL in the pituitary glands of adult ovariectomized ewes. Endocrinology. 126:1361–1367. 1990.

Toshinai K., Mondal MS., Nakazato M., Date Y., Murakami N., Kojima M., Kangawa K., Matsukura S. Upregulation of Ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration. Biochem Biophys Res Commun. 281:1220–1225. 2001a.

Toshinai K., Mondal SS., Nakazato M., Date Y., Murakami N., Kojima M., Kangawa K., Matsukura S. Upregulation of ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration. Biochem Biophys Res Commun. 281:1220–1225. 2001b.

Vuagnat BA., Pierroz DD., Lalaoui M., Englaro P., Pralong FP., Blum WF., Aubert ML. Evidence for a leptin-neuropeptide Y axis for the regulation of growth hormone secretion in the rat. Neuroendocrinology. 67:291–300. 1998.

Wilkinson CW., Engeland WC., Shinsako J., Dallman MF. Nonsteroidal adrenal feedback demarcates two types of pathways to CRF-ACTH release. Am J Physiol. 240:E136–E145. 1981.

Willesen MG., Kirstensen P., Romer J. Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat. Neuroendocrinology. 70:306–316. 1999.